Drug
Olesoxime clinical trials
Also written TRO19622.
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Studies
Open first, then newest update. How each study uses olesoxime is read from its arms, and is right about nine times in ten.
Testing it · 8
- Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedPhase 2Hoffmann-La RocheNCT00666016Written as TRO19622
- Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALSCompletedPhase 3Hoffmann-La RocheNCT00868166Written as Olesoxime
- A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)CompletedPhase 2Hoffmann-La RocheNCT02628743Written as Olesoxime
- Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral NeuropathyCompletedPhase 2Hoffmann-La RocheNCT00876538Written as Olesoxime (TRO19622)
- Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.CompletedPhase 2Hoffmann-La RocheNCT01302600Written as Olesoxime
- Safety Extension Study of TRO19622 in ALSCompletedPhase 2/3Hoffmann-La RocheNCT01285583Written as TRO19622
- Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.CompletedPhase 1Hoffmann-La RocheNCT01808885Written as olesoxime (TRO19622)
- A Study of the Excretion Balance of Radiocarbon and the Pharmacokinetics and Metabolic Profile of TRO19622 (Olesoxime)CompletedPhase 1Hoffmann-La RocheNCT02835976Written as Olesoxime
Codes
What other systems call olesoxime · ClinicalTrials.gg INT005155
- MeSH (NLM) C522838olesoximeConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) A6778U5IFYOLESOXIMEConfirmed FDA, NLM
- NCI Thesaurus C174604OlesoximeOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522838 | olesoxime | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | A6778U5IFY | OLESOXIME | Confirmed FDA, NLM |
| NCI Thesaurus | C174604 | Olesoxime | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.